146 related articles for article (PubMed ID: 15953282)
41. The need for annual echocardiography to detect cabergoline-associated valvulopathy in patients with prolactinoma: a systematic review and additional clinical data.
Caputo C; Prior D; Inder WJ
Lancet Diabetes Endocrinol; 2015 Nov; 3(11):906-13. PubMed ID: 25466526
[TBL] [Abstract][Full Text] [Related]
42. Cabergoline resistance in pediatric prolactinomas.
Spinks JJ; Ryan FJ
J Pediatr Hematol Oncol; 2009 May; 31(5):377-9. PubMed ID: 19415025
[TBL] [Abstract][Full Text] [Related]
43. Prolactinomas apparently resistant to quinagolide respond to cabergoline therapy.
Colao A; Lombardi G
J Clin Endocrinol Metab; 1997 Aug; 82(8):2756. PubMed ID: 9253368
[No Abstract] [Full Text] [Related]
44. Prolactinomas, cabergoline, and pregnancy.
Glezer A; Bronstein MD
Endocrine; 2014 Sep; 47(1):64-9. PubMed ID: 24985062
[TBL] [Abstract][Full Text] [Related]
45. Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline.
T'Sjoen G; Defeyter I; Van De Saffele J; Rubens R; Vandeweghe M
J Endocrinol Invest; 2002 Feb; 25(2):172-5. PubMed ID: 11929090
[TBL] [Abstract][Full Text] [Related]
46. Prolactinomas and pregnancy.
Molitch ME
Clin Endocrinol (Oxf); 2010 Aug; 73(2):147-8. PubMed ID: 20550542
[No Abstract] [Full Text] [Related]
47. A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy.
Soni A; De Silva SR; Allen K; Byrne JV; Cudlip S; Wass JA
Pituitary; 2008; 11(3):307-11. PubMed ID: 17899387
[TBL] [Abstract][Full Text] [Related]
48. An unusual case of Cushing's syndrome due to bihormonal ACTH-prolactin secreting pituitary macroadenoma with rapid response to cabergoline.
Kunasegaran S; Croxson MS; Holdaway I; Murphy R
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28784879
[TBL] [Abstract][Full Text] [Related]
49. Macular amyloidosis complicating macroprolactinoma--a novel clinical association.
Dutta D; Ahuja A; Sharma L; Bhardwaj M; Kulshreshtha B
Endokrynol Pol; 2015; 66(6):555-8. PubMed ID: 26662655
[TBL] [Abstract][Full Text] [Related]
50. High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy.
Banerjee A; Wynne K; Tan T; Hatfield EC; Martin NM; Williamson C; Meeran K
Clin Endocrinol (Oxf); 2009 May; 70(5):812-3. PubMed ID: 18803677
[No Abstract] [Full Text] [Related]
51. Resolution of macroprolactinoma-induced symptomatic hydrocephalus following cabergoline therapy.
Iglesias P; Macho LP; Díez JJ
Age Ageing; 2004 Jul; 33(4):410-2. PubMed ID: 15136289
[TBL] [Abstract][Full Text] [Related]
52. Prolactinomas.
Couldwell WT; Weiss MH; Laws ER
N Engl J Med; 2004 Mar; 350(10):1054-7; author reply 1054-7. PubMed ID: 15002121
[No Abstract] [Full Text] [Related]
53. Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas.
Biswas M; Smith J; Jadon D; McEwan P; Rees DA; Evans LM; Scanlon MF; Davies JS
Clin Endocrinol (Oxf); 2005 Jul; 63(1):26-31. PubMed ID: 15963057
[TBL] [Abstract][Full Text] [Related]
54. Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma.
Freeman B; Levy W; Gorman JM
J Psychiatr Pract; 2007 Mar; 13(2):120-4. PubMed ID: 17414690
[No Abstract] [Full Text] [Related]
55. Images in thyroidology. Left exophthalmos of endocrine nonthyroid origin in a seven-year-old boy.
Krassas GE; Pontikides N
Thyroid; 2000 Sep; 10(9):837-8. PubMed ID: 11041464
[No Abstract] [Full Text] [Related]
56. Evolution of a prolactin-secreting pituitary microadenoma into a fatal carcinoma: a case report.
Guastamacchia E; Triggiani V; Tafaro E; De Tommasi A; De Tommasi C; Luzzi S; Sabbà C; Resta F; Terreni MR; Losa M
Minerva Endocrinol; 2007 Sep; 32(3):231-6. PubMed ID: 17912159
[TBL] [Abstract][Full Text] [Related]
57. A comparison between intensive and conventional cabergoline treatment of newly diagnosed patients with macroprolactinoma.
Rastogi A; Bhansali A; Dutta P; Singh P; Vijaivergiya R; Gupta V; Sachdeva N; Bhadada SK; Walia R
Clin Endocrinol (Oxf); 2013 Sep; 79(3):409-15. PubMed ID: 23347435
[TBL] [Abstract][Full Text] [Related]
58. Successful Improvement of Metabolic Disorders, Including Osteopenia, by a Dopamine Agonist in a Male Patient with Macro-Prolactinoma.
Takeno A; Yamamoto M; Okazaki K; Yamaguchi T; Sugimoto T
Am J Case Rep; 2016 Mar; 17():160-4. PubMed ID: 26971354
[TBL] [Abstract][Full Text] [Related]
59. Obstructive hydrocephalus and intracranial hypertension caused by a giant macroprolactinoma. Prompt response to medical treatment.
Scarone P; Losa M; Mortini P; Giovanelli M
J Neurooncol; 2006 Jan; 76(1):51-4. PubMed ID: 16205966
[TBL] [Abstract][Full Text] [Related]
60. Cabergoline can induce mania with psychotic features in bipolar I disorder: a case report.
Rovera C; Cremaschi L; Thanju A; Fiorentini A; Mauri MC; Serati M; Lindenmayer JP; Altamura AC
Asian J Psychiatr; 2016 Aug; 22():94-5. PubMed ID: 27520906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
